Our life’s work

Read Bio

Osama Hamdy, MD, PhD is a senior endocrinologist and Medical Director of the Joslin Obesity Clinical Program, and Director of the Inpatient Diabetes Program at Joslin Diabetes Center. He is also an Associate Professor of Medicine at Harvard Medical School. He is a world recognized expert and thought leader with 34 years of extensive clinical experience in nutrition and obesity research. His lab led to innovations in how we manage obesity in patients with type 1 or type 2 diabetes. Dr. Hamdy’s research discovered that 7% weight loss in obese patients with and without diabetes significantly improves vascular endothelial function, insulin sensitivity and markers of inflammation. Dr. Hamdy was a co-investigator in landmark studies: the “Diabetes Prevention Program” and “the Look AHEAD Study.” Dr. Hamdy founded the “Weight Achievement and Intensive Treatment” (Why WAIT) program, helping patients with diabetes to be less dependent on diabetes medications. Dr. Hamdy co-chaired the task force that developed the global transcultural Diabetes Nutrition Algorithm (tDNA). His research led to changes in the standards of diabetes care and lifestyle management by the American Diabetes Association and the American Association of Clinical Endocrinologists. Dr. Hamdy received the Michaela Modan Award of the American Diabetes Association and the Compassionate Caregiver Award of the Kenneth Schwartz Center. He has more than 150 peer-reviewed original articles, reviews and book chapters. He is also the author of the Harvard Health Publication “The Diabetes Breakthrough” reversing diabetes through weight management. He is on the editorial review board of many medical journals including Lancet, JAMA, British Medical Journal, Diabetes Care and Current Diabetes Report.

Read Bio

Elbert Huang, MD is Professor of Medicine and Public Health Sciences, Director of the Center for Chronic Disease Research and Policy, and Associate Director of the Chicago Center for Diabetes Translation Research at the University of Chicago. From 2010-2011, he served as a Senior Advisor in the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. Dr. Huang is a general internist who studies clinical and health care policy issues at the intersection of diabetes, aging, and health economics. His main research focus is in the area of medical decision making for elderly patients with type 2 diabetes where uncertainty exists regarding how to best individualize diabetes treatments based on clinical parameters and patient preferences. Over the past two decades, Dr. Huang has established one of the most active research programs in geriatric diabetes in the country. Dr. Huang’s research has been supported by the National Institutes of Health, the Centers for Disease Control and Prevention, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. He has received numerous honors including the Research Paper of the Year Award from the Society of General Internal Medicine and elected membership to the American Society for Clinical Investigation. Dr. Huang received his AB, MD, and MPH from Harvard University and came to the University of Chicago in 2001.

Read Bio

Francine R. Kaufman, MD is the Chief Medical Officer of Senseonics, Inc. (2019-present). Previously, she was the CMO and VP of Global Medical Affairs at Medtronic Diabetes (2009-2019). She is a Distinguished Professor Emerita of Pediatrics at the Keck School of Medicine of the University of Southern California. After joining the Division of Endocrinology at Children’s Hospital Los Angeles in 1980, she served as Director of Diabetes (1990-2001) and then Division Head of Endocrinology (2001-2009). She has authored over 290 peer-reviewed and invited articles, and numerous books including Diabesity (Bantam, 2005), The Medical Management of Type 1 Diabetes (ADA, 2008), The Insulin Pump and Continuous Glucose Monitoring Book: For Patients, Parents and Caregivers (ADA, 2012, 2017) and Rhythms (a novel) (CKI Publisher, 2015). She has received numerous grants, including being funded by the NIH for over 3 decades. She was elected to the National Academy of Medicine in 2005. Dr. Kaufman was national president of the ADA (2002-2003). She directed diabetes camps in Southern California, Ecuador, and Haiti for over 30 years. She was instrumental in banning sodas from LA Unified School District in 2004.

Read Bio

Dr. Mechanick is a Professor of Medicine and Medical Director of The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Director of Metabolic Support in the Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai. He received his M.D. degree from the Icahn School of Medicine at Mount Sinai, completed Internal Medicine residency at Baylor College of Medicine, and completed Endocrine Fellowship at The Mount Sinai Hospital. Dr. Mechanick authored over 386 publications in Endocrinology, Metabolism, and Nutrition Support with 272 PubMed citations currently. He is the 2016-2017 Past President of the American College of Endocrinology, 2013-2014 Past President of the American Association of Clinical Endocrinologists, and 2005-2006 Past President of the American Board of Physician Nutrition Specialists. Dr. Mechanick co-edited Nutritional Strategies for the Diabetic and Prediabetic Patient; Power of Prevention: The Complete Guide to Lifelong Nutrition; Thyroid Cancer: From Emergent Biotechnology to Clinical Practice Guidelines; Molecular Nutrition – The Practical Guide, Lifestyle Medicine – A Manual for Clinical Practice, and Creating a Lifestyle Medicine Center; and co-authored Diabetes Mellitus Pocket and Nutritional Medicine Pocket. Dr. Mechanick was appointed as a member of the President’s Council on Fitness, Sports and Nutrition (PCFSN) Science Board for 2010-2013 and was the 2013-2015 Editor-in-Chief and is currently Editor-in-Chief Emeritus of the PCFSN quarterly publication Elevate Health. Dr. Mechanick chairs the Physician Engagement Committee of the American Association for Parenteral and Enteral Nutrition. Dr. Mechanick also chairs the International Transcultural Diabetes Nutrition Algorithm Working Group. Dr. Mechanick currently serves as Chair of the Board of Visitors for the College of Computer, Mathematics, and Natural Sciences at the University of Maryland at College Park and was the 2011 recipient of the University of Maryland Industry Impact Award and 2011 University of Maryland Biology Alumnus Award. Dr. Mechanick’s research interests are in the fields of nutrition and metabolic support, obesity and lifestyle medicine, and network analysis of complex systems. Dr. Mechanick is responsible for training cardiology fellows at Mount Sinai Heart in preventive cardiology.

Read Bio

Ambrish Mithal, MD is an endocrinologist and the Chairman and Head of Endocrinology and Diabetes at Max Healthcare, Saket, New Delhi; he started working in December 2019. One of the most renowned names in the field of Endocrinology, Dr. Ambrish Mithal is considered to be a thought leader in the medical community. Before joining Max Healthcare, he was Chairman, Division of Endocrinology and Diabetes, at Medanta the Medicity. There, he led the Endocrinology and Diabetes division from 2009 to 2019. Before that, he worked at Apollo Hospital, New Delhi, and Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow. More recently, in 2019, Dr. Mithal has been nominated to the Governing Council of the National Health Authority, the apex body involved in implementing the ambitious population health coverage plan of the government. He has also been appointed (honorary) President, All India Institute of Medical Sciences, Gorakhpur. Dr. Mithal was awarded the International Osteoporosis Foundation President's Award in March 2016. In March 2017, Dr. Mithal was awarded the Dr. B C Roy Award by the President of India for his contribution to the development of endocrinology in India. He has won numerous awards from medical and social bodies throughout his career.

Read Bio

Rohit Satoskar, MD, is the Director of Medical Services for the MedStar Georgetown Transplant Institute. He is also medical director of Liver Transplantation and Associate professor in the Department of Medicine at the MedStar Georgetown Transplant Institute. An expert in hepatology and liver transplantation, Dr. Satoskar is board-certified in Internal Medicine, Gastroenterology and Transplant Hepatology. He is widely published and a frequent lecturer, regionally and nationally. In addition to Dr. Satoskar's role as a clinician, teacher and researcher, he is actively involved in public policy efforts to benefit patients with liver disease. He serves in leadership positions with professional societies such as the American Association for the Study of Liver Diseases and the American Liver Foundation and is a founding board member of the Global Liver Institute dedicated to collaboration and innovation in dealing with liver disease. Dr. Satoskar is highly rated by patients for explaining things well, listening carefully, and treating patients with respect, among other things. He believes in personalized care for each patient to address their particular needs and help achieve the best possible outcome and quality of life. Each patient is cared for as an individual, using the latest evidence-based medicine and technology available.

Read Bio

Patrick Conway, MD, MSc, currently serves as the CEO of Care Solutions at Optum, part of UnitedHealth Group where he leads a portfolio of care continuum businesses with over $20 billion in annual revenue serving tens of millions of people across acute and post-acute care, care in the home in-person and virtually, mental and behavioral care benefits and delivery, broad population and complex disease health management, specialty care, and government health services. From 2017-2019, he was President and CEO of Blue Cross and Blue Shield of North Carolina leading the organization to be recognized nationally for innovation, value-based payment, and investments in better health outcomes. From 2011-17, Conway served as Deputy Administrator for Innovation and Quality at the federal Centers for Medicare and Medicaid Services (CMS) and as Director of the Center for Medicare and Medicaid Innovation (CMMI) and the agency’s Chief Medical Officer. Before joining CMS, he oversaw clinical operations and quality improvement at Cincinnati Children’s Hospital Medical Center. He remains a practicing pediatric hospitalist. A respected leader, innovator and clinician, he was elected to the National Academy of Medicine (NAM) in 2014, received the President’s Senior Executive Distinguished Service award, and was a White House Fellow in 2007-08.

Read Bio

Michelle Harika, PharmD, is a principal at Blackstone and Chief Clinical Officer for Equity Healthcare, where she is responsible for oversight and performance of a customized clinical model operated by multiple vendors. Dr. Harika also leads improvement initiatives designed to improve health, generate savings, and increase value to Blackstone’s portfolio companies. Before coming to Blackstone, Dr. Harika practiced pharmacy with a specialty in diabetes management, followed by 10 years with Anthem, where she was responsible for clinical program performance and improvement strategies.Dr. Harika serves on the advisory boards for HealthTrust’s PBM coalition and is a senior advisor for Tuft’s NewDIGs Initiative. She is an active participant in the Global Chief Medical & Health Officer Network Community and past president of the Central Virginia Association of Diabetes Educators. In addition to serving on the board of the Richmond Pharmacists Association, Dr. Harika volunteers as a member of the Virginia Medical Reserves Corp. Dr. Harika received her doctorate from the Medical College of Virginia School of Pharmacy.

Read Bio

Shashank Joshi, MD is Twin's chief scientist. As an endocrinologist and medical researcher, Dr. Joshi has extensive experience with the treatment and study of diabetes and chronic disease. Before joining Twin, he was the Chair of the South-East Asian International Diabetes Federation and president of several organizations: the Indian Academy of Diabetes, the Endocrine Society of India, the Association of Physicians of India, and the Research Society for Study of Diabetes in India. Dr. Joshi was a member of the faculty at Grant Medical College and Seth GS Medical College, where he earned his MBBS and MD, respectively. He is a fellow of the American College of Endocrinology, the American College of Physicians, and the Royal College of Physicians (London, Glasgow, and Edinburgh). Dr. Joshi has published more than 800 research publications and Stanford University ranked him in the Top 0.5% of all scientists in General and Internal Medicine.

Read Bio

Frank Williams is the Co-Founder and Executive Chairman of Evolent Health (NYSE: EVH) and previously served as the company’s Chairman and CEO between 2011 and 2020. Frank also served as Chairman and CEO of The Advisory Board Company (NASDAQ: ABCO), a global research and technology firm that serves over 5,000 organizations across the healthcare and higher education sectors. During Frank's tenure as both its’ Chairman and CEO, The Advisory Board completed an initial public offering and grew to $450M+ in annual revenues with over 2,500 employees and $2B+ in market capitalization. Along with the Evolent Health board, he currently serves on the boards of the Business Talent Group, Peer Health Exchange, Syapse and Passport Health Plan. Frank is active philanthropically in initiatives related to Public Health and Education. A native Californian, Frank received a BA in Political Economy from UC Berkeley and an MBA from Harvard Business School.

Read Bio

Ronald A. Williams is Chairman and CEO of RW2 Enterprises and the former Chairman and CEO of health insurance giant Aetna Inc. He’s the bestselling author of “Learning to Lead: The Journey to Leading Yourself, Leading Others, and Leading an Organization”. Mr. Williams counsels C-Suite corporate executives on strategy and transformational leadership. As Operating Advisor to private equity firm Clayton Dubilier & Rice, he oversees portfolio companies including serving as Founding Chairman of agilon health and Chairman of Vera Whole Health. He previously served as Chairman of naviHealth and PharMedium. He is a Director of American Express, Boeing and Johnson & Johnson, and Warby Parker Mr. Williams is Chairman of The Conference Board and member of President’s Circle of the National Academies, American Academy of Arts and Sciences and trustee of CED. He’s a graduate of Roosevelt University and holds an M.S. in Management from MIT Sloan School of Management.